(Q48621181)

13 February 2018

title

Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. (English)

1 reference

13 February 2018

0 references

0 references

1 reference

4

1 reference

13 February 2018

author name string

B Sköldenberg

1

1 reference

13 February 2018

M Forsgren

2

1 reference

13 February 2018

K Alestig

3

1 reference

13 February 2018

L Burman

5

1 reference

13 February 2018

E Dahlqvist

6

1 reference

13 February 2018

A Forkman

7

1 reference

13 February 2018

A Frydén

8

1 reference

13 February 2018

K Lövgren

9

1 reference

13 February 2018

K Norlin

10

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 September 1984

1 reference

13 February 2018

published in

The Lancet

1 reference

13 February 2018

volume

2

1 reference

13 February 2018

issue

8405

1 reference

13 February 2018

page(s)

707-711

1 reference

13 February 2018

Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992623-0

7 January 2021

Herpes simplex encephalitis: vidarabine therapy and diagnostic problems

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992623-0

7 January 2021

Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992623-0

7 January 2021

The spectrum of antiviral activities of acyclovir in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992623-0

7 January 2021

INTRAVENOUS ACYCLOVIR TREATMENT FOR PRIMARY GENITAL HERPES

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992623-0

7 January 2021

Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992623-0

7 January 2021

Long-term persistence of intrathecal virus-specific antibody responses after herpes simplex virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992623-0

7 January 2021

Failure of high dose 5-iodo-2'-deoxyuridine in the therapy of herpes simplex virus encephalitis. Evidence of unacceptable toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992623-0

7 January 2021

Herpes Simplex Virus Encephalitis: Laboratory Evaluations and Their Diagnostic Significance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992623-0

7 January 2021

Rapid diagnosis of encephalitis by immunofluorescent examination of cerebrospinal-fluid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992623-0

7 January 2021

Diagnosis of virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992623-0

7 January 2021

Purification and characterization of proteins excreted by cells infected with herpes simplex virus and their use in diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992623-0

7 January 2021

Antibodies to herpes-simplex virus in the cerebrospinal fluid of patients with herpetic encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992623-0

7 January 2021

RAPID NON-INVASIVE DIAGNOSIS OF HERPES ENCEPHALITIS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992623-0

7 January 2021

Diagnostic value of cerebrospinal fluid antibodies in herpes simplex virus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992623-0

7 January 2021

Mumps meningitis: specific and non-specific antibody responses in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2884%2992623-0

7 January 2021

10.1016/S0140-6736(84)92623-0

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018